These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16145573)

  • 1. A plague upon the phagocytes.
    DeLeo FR; Hinnebusch BJ
    Nat Med; 2005 Sep; 11(9):927-8. PubMed ID: 16145573
    [No Abstract]   [Full Text] [Related]  

  • 2. Deadly plague versus mild-mannered TLR4.
    Dziarski R
    Nat Immunol; 2006 Oct; 7(10):1017-9. PubMed ID: 16985495
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological characterisation of sub-units of the Yersinia type III secretion apparatus.
    Hill J; Underwood CD; Sundberg L; Aström H; Leary SE; Forsberg A; Titball RW
    Adv Exp Med Biol; 2003; 529():415-7. PubMed ID: 12756800
    [No Abstract]   [Full Text] [Related]  

  • 4. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
    Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
    Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale purification of the F1 antigen of Yersinia pestis.
    Reddin KM; Easterbrook TJ; Robinson A; Williamson D; Rhind-tutt R
    Contrib Microbiol Immunol; 1995; 13():329-30. PubMed ID: 8833865
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
    Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
    Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A molecular basis of the plague vaccine development].
    Dentovskaia SV; Kopylov PKh; Ivanov SA; Ageev SA; Anisimov AP
    Mol Gen Mikrobiol Virusol; 2013; (3):3-12. PubMed ID: 24364139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behavior in vivo of strains of Pasteurella pestis in relation to their efficacy as live vaccines].
    Markenson J; Ben-Efraim S
    Ann Inst Pasteur (Paris); 1969 Aug; 117(2):196-212. PubMed ID: 5406056
    [No Abstract]   [Full Text] [Related]  

  • 10. Plague into the 21st century.
    Butler T
    Clin Infect Dis; 2009 Sep; 49(5):736-42. PubMed ID: 19606935
    [No Abstract]   [Full Text] [Related]  

  • 11. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
    Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
    Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dam mutant of Yersinia pestis is attenuated and induces protection against plague.
    Robinson VL; Oyston PC; Titball RW
    FEMS Microbiol Lett; 2005 Nov; 252(2):251-6. PubMed ID: 16188402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery.
    Tripathi V; Chitralekha KT; Bakshi AR; Tomar D; Deshmukh RA; Baig MA; Rao DN
    Vaccine; 2006 Apr; 24(16):3279-89. PubMed ID: 16476510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plague.
    Henderson RJ
    Trop Dis Bull; 1969 Jul; 66(7):653-9. PubMed ID: 4896220
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current state of problem of improving tools for plague vaccine prophylaxis].
    Byvalov AA; Kutyrev VV
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):97-104. PubMed ID: 21598626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A plant-produced plague vaccine candidate confers protection to monkeys.
    Mett V; Lyons J; Musiychuk K; Chichester JA; Brasil T; Couch R; Sherwood R; Palmer GA; Streatfield SJ; Yusibov V
    Vaccine; 2007 Apr; 25(16):3014-7. PubMed ID: 17287055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED; Flick-Smith HC; Waters E; Miller J; Hodgson I; Le Butt CS; Hill J
    Microb Pathog; 2007 Jan; 42(1):11-21. PubMed ID: 17107769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.
    Montminy SW; Khan N; McGrath S; Walkowicz MJ; Sharp F; Conlon JE; Fukase K; Kusumoto S; Sweet C; Miyake K; Akira S; Cotter RJ; Goguen JD; Lien E
    Nat Immunol; 2006 Oct; 7(10):1066-73. PubMed ID: 16980981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague.
    Reed DS; Martinez MJ
    Vaccine; 2006 Mar; 24(13):2283-9. PubMed ID: 16377037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.